Literature DB >> 6102261

Combined prazosin and hydralazine in resistant hypertension.

G I Russell, S Swart, R F Bing, H Thurston, J D Swales.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6102261     DOI： 10.1016/s0140-6736(80)92796-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Hydralazine and prazosin in the treatment of hypertension.

Authors:  M J Vandenburg; V L Sharman; P Wright; P J Drew; J N Barnes
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

Review 2.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.